Nathalie Dompé is CEO of Dompé farmaceutici. Nathalie is responsible for the oversight, market development, and strategic approval of all new drugs launched by Dompé in the United States. She explores new opportunities for the company through interactions with other business leaders in the pharmaceutical and high-tech industries. Nathalie is currently CEO of Dompé Holdings, a diversified holding company in Europe with business interests in pharmaceuticals, agriculture, and hi-tech. She sits on the Boards of several companies including Movendo, Philogen and Dompé farmaceutici. Nathalie holds a degree in Business Administration from Bocconi University in Milan.